Tower Research Capital LLC (Trc) Arbutus Biopharma Corp Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 12,779 shares of ABUS stock, worth $42,042. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,779
Previous 10,879
17.46%
Holding current value
$42,042
Previous $41,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding ABUS
# of Institutions
164Shares Held
102MCall Options Held
649KPut Options Held
666K-
Morgan Stanley New York, NY22.6MShares$74.3 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.2MShares$43.6 Million22.74% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.98MShares$29.5 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.74MShares$28.8 Million4.68% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $493M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...